DFE PHARMA INDIA PRIVATE LIMITED
OVERVIEW - DFE PHARMA INDIA PRIVATE LIMITED
Dfe Pharma India Private Limited is an unlisted private company incorporated on 15 May, 2019. It is classified as a private subsidiary of a foreign company and is located in Cuddalore, Tamil Nadu. It's authorized share capital is INR 61.12 cr and the total paid-up capital is INR 61.12 cr.
Dfe Pharma India's operating revenues range is INR 100 cr - 500 cr for the financial year ending on 31 March, 2022. It's EBITDA has increased by 37.82 % over the previous year. At the same time, it's book networth has increased by 17.91 %. Other performance and liquidity ratios are available here.
The current status of Dfe Pharma India Private Limited is - Active.
The last reported AGM (Annual General Meeting) of Dfe Pharma India Private Limited, per our records, was held on 29 December, 2023.
Dfe Pharma India Private Limited has four directors - Martti Tapani Ossian Hedman, Aditya Chitharanjan, and others.
The Corporate Identification Number (CIN) of Dfe Pharma India Private Limited is U24299TN2019FTC129309. The registered office of Dfe Pharma India Private Limited is at B-4, SIPCOT Industrial Complex Kudikadu NA, CUDDALORE, Cuddalore, Tamil Nadu.
Company360 plans
Know more about your vendors, clients and competitors.
Financials, scores, ratios, excels, reports and more.
@ INR 9000/quarter
Join our newsletter
REGISTERED DETAILS - DFE PHARMA INDIA PRIVATE LIMITED
CIN
U24299TN2019FTC129309
Incorporation Date / Age
15 May, 2019 / 5 yrs
Last Reported AGM Date
29 December, 2023
Authorized Capital
INR 6112.1 Lacs
Paidup Capital
INR 6112.0383 Lacs
industry*
Manufacturing (Chemicals and chemical products)
type
Unlisted Private Company
category
Company limited by Shares
subcategory
Subsidiary of Foreign Company
Registered Address
B-4, SIPCOT Industrial Complex Kudikadu NA
CUDDALORE
Cuddalore - 607005
Tamil Nadu - India
How to download DFE PHARMA INDIA PRIVATE LIMITED report
A Company report by Tofler is an easy-to-read PDF report that includes company's financial information, ratio analysis, management, group structure, shareholding pattern and more. Such reports can be bought from company pages at Tofler (Sample) or can be downloaded from Company360. Here is the video showing how a report downloaded from Company360 looks like.
DFE PHARMA INDIA PRIVATE LIMITED - Registration Details | ||||||
---|---|---|---|---|---|---|
CIN | U24299TN2019FTC129309 | |||||
Incorporation Date / Age | 15 May, 2019 / 5 yrs | |||||
Last Reported AGM Date | 29 December, 2023 | |||||
Authorized Capital | INR 6112.1 Lacs | |||||
Paidup Capital | INR 6112.0383 Lacs | |||||
industry* | Manufacturing (Chemicals and chemical products) | |||||
type | Unlisted Private Company | |||||
category | Company limited by Shares | |||||
subcategory | Subsidiary of Foreign Company | |||||
Email Address | ||||||
Website | ||||||
Registered Address | B-4, SIPCOT Industrial Complex Kudikadu NA CUDDALORE Cuddalore - 607005 Tamil Nadu - India |
FINANCIAL HIGHLIGHTS - DFE PHARMA INDIA PRIVATE LIMITED
Operating Revenue | INR 100 cr - 500 cr |
EBITDA | 37.82 % |
Networth | 17.91 % |
Debt/Equity Ratio | 0.38 |
Return on Equity | 15.20 % |
* Company has reported to have approved financials for 31 March, 2023. However, in case, they are not available at MCA because of non-filing or damage, then we will provide the latest financials downloadable from MCA.
How to get financial reports of DFE PHARMA INDIA PRIVATE LIMITED
Tofler Company360 provides access to any Indian company's financial documents, charts, ratio analysis and more. It lets you compare financials of several companies and study performance trends. These financials can also be downloaded in excel format. Here is the video showing how you can study the financials of an Indian company on the Company360 platform.
Directors - DFE PHARMA INDIA PRIVATE LIMITED
The company has 4 directors and 1 reported key management personnel.
The longest serving director currently on board is Jaya Prabbu Subbaraj who was appointed on 01 November, 2019. Jaya Prabbu Subbaraj has been on the board for 4 years and 5 months. The most recently appointed director is Martti Tapani Ossian Hedman, who was appointed on 26 April, 2022.
Aditya Chitharanjan has the largest number of other directorships with a seat at a total of 2 companies. In total, the company is connected to 1 other companies through its directors.
NAME | DESIGNATION | APPOINTMENT DATE | |
---|---|---|---|
MARTTI TAPANI OSSIAN HEDMAN | Director | 26 April, 2022 | No other directorships |
ADITYA CHITHARANJAN | Director | 01 January, 2021 | Other directorships - CHITH WAREHOUSE PRIVATE LIMITED, |
JAYA PRABBU SUBBARAJ | Director | 01 November, 2019 | No other directorships |
PREETAM TALANKI NAGARAJA SHETTY | Director | 01 April, 2022 | No other directorships |
Nikita Khandelwal | KMP | 20 March, 2020 | No other directorships |
NAME | DESIGNATION | APPOINTMENT DATE | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MARTTI TAPANI OSSIAN HEDMAN | Director | 26 April, 2022 | No other directorships | ||||||||||||||||
|
|||||||||||||||||||
ADITYA CHITHARANJAN | Director | 01 January, 2021 | View other directorships | ||||||||||||||||
|
|||||||||||||||||||
JAYA PRABBU SUBBARAJ | Director | 01 November, 2019 | No other directorships | ||||||||||||||||
|
|||||||||||||||||||
PREETAM TALANKI NAGARAJA SHETTY | Director | 01 April, 2022 | No other directorships | ||||||||||||||||
|
|||||||||||||||||||
Nikita Khandelwal | KMP | 20 March, 2020 | No other directorships | ||||||||||||||||
|
Director
Nikita Khandelwal
KMP
Director
PREETAM TALANKI NAGARAJA SHETTY
Director
Director
Previous Names
No previous names were found for this company. |
Previous CINs
No previous CINs were found for this company. |
SIMILAR COMPANIES
NAME | INCORPORATION YEAR | STATE | PAID UP CAPITAL | |
---|---|---|---|---|
CORONA REMEDIES PRIVATE LIMITED
It was formed in year 2004 in Gujarat . The company currently has a paid up capital of INR 61.16 cr.
|
2004 | Gujarat | 61.16 cr | Buy financial reports |
CIPLA PHARMACEUTICALS LIMITED
It was formed in year 2019 in Maharashtra . The company currently has a paid up capital of INR 60.81 cr.
|
2019 | Maharashtra | 60.81 cr | Buy financial reports |
CREST CELLULOSE PRIVATE LIMITED
It was formed in year 2012 in Maharashtra . The company currently has a paid up capital of INR 60.55 cr.
|
2012 | Maharashtra | 60.55 cr | Buy financial reports |
ADCOCK INGRAM PHARMA PRIVATE LIMITED
It was formed in year 2021 in Karnataka . The company currently has a paid up capital of INR 60.50 cr.
|
2021 | Karnataka | 60.50 cr | Buy financial reports |
RAJASTHAN EXPLOSIVES AND CHEMICALS LIMITED
It was formed in year 1979 in Maharashtra . The company currently has a paid up capital of INR 59.74 cr.
|
1979 | Maharashtra | 59.74 cr | Buy financial reports |
RAJASTHAN EXPLOSIVES AND CHEMICALS LIMITED
It was formed in year 1979 in Delhi . The company currently has a paid up capital of INR 59.74 cr.
|
1979 | Delhi | 59.74 cr | Buy financial reports |
FUJIFILM INDIA PRIVATE LIMITED
It was formed in year 2007 in Delhi . The company currently has a paid up capital of INR 62.59 cr.
|
2007 | Delhi | 62.59 cr | Buy financial reports |
MERIL LIFE SCIENCES PRIVATE LIMITED
It was formed in year 2007 in Gujarat . The company currently has a paid up capital of INR 59.36 cr.
|
2007 | Gujarat | 59.36 cr | Buy financial reports |
SIRIMAN CHEMICALS INDIA PRIVATE LIMITED
It was formed in year 2016 in Telangana . The company currently has a paid up capital of INR 62.89 cr.
|
2016 | Telangana | 62.89 cr | Buy financial reports |
IND SWIFT LABORATORIES LIMITED
It was formed in year 1995 in Chandigarh . The company currently has a paid up capital of INR 59.09 cr.
|
1995 | Chandigarh | 59.09 cr | Buy financial reports |
NAME | INCORPORATION YEAR | STATE | PAID UP CAPITAL |
---|---|---|---|
CORONA REMEDIES PRIVATE LIMITED | 2004 | Gujarat | 61.16 cr |
CIPLA PHARMACEUTICALS LIMITED | 2019 | Maharashtra | 60.81 cr |
CREST CELLULOSE PRIVATE LIMITED | 2012 | Maharashtra | 60.55 cr |
ADCOCK INGRAM PHARMA PRIVATE LIMITED | 2021 | Karnataka | 60.50 cr |
RAJASTHAN EXPLOSIVES AND CHEMICALS LIMITED | 1979 | Maharashtra | 59.74 cr |
RAJASTHAN EXPLOSIVES AND CHEMICALS LIMITED | 1979 | Delhi | 59.74 cr |
FUJIFILM INDIA PRIVATE LIMITED | 2007 | Delhi | 62.59 cr |
MERIL LIFE SCIENCES PRIVATE LIMITED | 2007 | Gujarat | 59.36 cr |
SIRIMAN CHEMICALS INDIA PRIVATE LIMITED | 2016 | Telangana | 62.89 cr |
IND SWIFT LABORATORIES LIMITED | 1995 | Chandigarh | 59.09 cr |
SUBSIDIARY COMPANIES
No Indian subsidiary companies found.
Company Network - DFE PHARMA INDIA PRIVATE LIMITED
How to use company network of DFE PHARMA INDIA PRIVATE LIMITED
Tofler Company network is a powerful feature that allows you to explore and discover common directorships between companies. It helps you find out other directorships of an Indian director and where else he has business interests. The feature is available for unlimited use in Company360 platform. Here is the video showing how you can explore company networks to discover hidden relationships between companies.
FAQ - DFE PHARMA INDIA PRIVATE LIMITED
-
What is the Incorporation date of DFE PHARMA INDIA PRIVATE LIMITED?
The Incorporation Date of DFE PHARMA INDIA PRIVATE LIMITED is 15 May, 2019.
-
What is the operating revenue of DFE PHARMA INDIA PRIVATE LIMITED?
The operating revenue of DFE PHARMA INDIA PRIVATE LIMITED is in the range of INR 100 cr - 500 cr for the financial year ending on 31 March, 2022.
-
What is the change in EBITDA of DFE PHARMA INDIA PRIVATE LIMITED since last year?
The EBITDA of DFE PHARMA INDIA PRIVATE LIMITED has increased by 37.82 % over the previous year. At the same time, it's book networth has increased by 17.91 % for the financial year ending 31 March, 2022.
-
Who are the directors of DFE PHARMA INDIA PRIVATE LIMITED?
Dfe Pharma India Private Limited has four directors - Martti Tapani Ossian Hedman, Aditya Chitharanjan, and others.
Company360 plans
Know more about your vendors, clients and competitors.
Financials, scores, ratios, excels, reports and more.
@ INR 9000/quarter
Join our newsletter
Send e-mail
DFE PHARMA INDIA PRIVATE LIMITED
Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to their respective owners. Read More